Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » BioCore, SolGent, Seasun Get FDA Emergency Use Authorizations for Coronavirus Tests

BioCore, SolGent, Seasun Get FDA Emergency Use Authorizations for Coronavirus Tests

May 22, 2020
|
staff reporter

NEW YORK — The US Food and Drug Administration on Thursday granted separate Emergency Use Authorizations (EUAs) for PCR-based SARS-CoV-2 tests developed by South Korean diagnostic test makers BioCore, SolGent, and Seasun Biomaterials.

The BioCore 2019-nCoV Real Time PCR Kit is designed to detect the SARS-CoV-2 N and RdRp genes in upper and lower respiratory specimens including nasopharyngeal swabs, sputum, and bronchoalveolar lavage.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

This One Might Not Be Due to Humans

A new analysis suggests warming, not the arrival of humans, led to the extinction of the woolly rhinoceros thousands of years ago, the Economist reports.

Not the Wings

Chinese health officials uncovered SARS-CoV-2 viral RNA on imported frozen food, but the New York Times reports catching COVID-19 that way would be unlikely.

More Vaccines on Order

The UK has ordered 60 million coronavirus vaccine doses from Novavax and 30 million doses from Janssen, according to the Guardian.

Science Studies Include Ion Channel Mutation Prediction Model, Variant Linked to Disrupted Sleep

In Science this week: machine learning model predicts whether ion channel mutations will cause disease, and more.

Aug
18
Featured Webinar

COVID-19 Wastewater-Based Epidemiology: Methods and Insights for SARS-CoV-2 Community Surveillance

Sponsored by
Bio-Rad

As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Aug
24
Featured Webinar

Utility of Novel RNA-Based Tools in Oncology Drug Development

Sponsored by
Genecentric

This webinar, Part 1 of the “Advances in RNA-based Biomarker Development for Precision Oncology” webinar series sponsored by GeneCentric Therapeutics, will discuss how gene expression signatures can accelerate (and rehabilitate) drug programs, define targeted patient populations, expand drug indications, and improve clinical success.

Aug
24
Featured Webinar

High-Definition Spatial Proteomics to Elucidate the Tumor Immune Microenvironment: A Dana-Farber Case Study

Sponsored by
IONPath

This webinar will discuss how high-definition spatial proteomics, enabled by Multiplexed Ion Beam Imaging (MIBI), can be used to explore the immune microenvironment of tumor biopsy samples, illustrated by a case study at Dana-Farber Cancer Institute.

Aug
25
Featured Webinar

Liquid Biopsy-based Molecular Risk Stratification of ALK-mutated Lung Cancer Patients

Sponsored by
Roche

Non-small cell lung cancer (NSCLC) patients with ALK rearrangements are treated with tyrosine kinase inhibitors (TKIs), which often leads to prolonged overall survival. However, treatment resistance will almost inevitably occur, and the disease remains incurable.

What's Popular?

In Molecular Diagnostics

  1. Myriad Genetics Q4 Revenues Plummet 57 Percent on Coronavirus Pandemic Pressures

  2. Thermo Fisher Scientific Terminates Qiagen Acquisition Agreement

  3. Many Initiatives Turning to RT-LAMP as Alternative to PCR for Rapid COVID-19 Screening Assays

    Premium

  4. Progenity Q2 Revenues Fall 70 Percent in First Earnings Report Since IPO

  5. HHS Invests $6.5M in Aegis Sciences, Sonic Healthcare USA to Expand Coronavirus Testing Capacity

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.